LYCO administered 3 days before IBD produced significant (p < 0.05, 0.001, n = 6) reduction in mean colonic MPO levels from 6907.45 ± 1007.17 in the untreated group (IBD, no LYCO) to 1121.19 ± 577.30 ng/mg of protein and from 5890.60 ± 1438.66 to 1877.65 ± 850.41 ng/mg of protein, at 2 and 4 days of IBD, respectively. Here, MPO is linked to inflammatory bowel disease.